
Sign up to save your podcasts
Or


Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.
By The Lancet NeurologyTobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.

43,687 Listeners

299 Listeners

503 Listeners

53 Listeners

113,121 Listeners

94 Listeners

518 Listeners

189 Listeners

59 Listeners

80 Listeners

0 Listeners